L7 MES
Time to challenge the MES status quo.
The manufacturing of pharmaceutical products is fraught with complexity and time constraints, frequently leading to delays, deviations, and escalating costs. Traditional methods rely on cumbersome, paper-based ecosystems and inflexible electronic systems, further compounded by non-compliant spreadsheets that create bottlenecks and delay product releases.
Introducing L7 MES.
L7 MES is a flexible, digital, and process-oriented solution designed to overcome traditional pharmaceutical manufacturing bottlenecks, while ensuring 21 CFR Part 11 compliance for the production of small molecules, biologics, and cell and gene therapy products.
Efficient recipient management
Rapid configuration of Master Batch Records, Intermediates, and Drug Product recipes.
Enhanced operational control
Supports configurable electronic signatures, sample plan management, and label reconciliation.
Comprehensive documentation integration
Enables Electronic Batch Records (EBR), Bill of Materials (BOM), Sample Plan Management, Specifications, Quality Review, Signature Sign-Off, and automatic Batch Reports.
L7 MES outperforms traditional MES point solutions.
L7 MES is integrated into the L7|ESP unified platform, sharing a common database with LIMS and inventory systems. It leverages the existing L7|ESP workflow configurations to accurately represent and manage the manufacturing process. Throughout production, it collects samples to be analyzed by LIMS. Additionally, L7|ESP supports enhancements with data trending and charting tools, enabling both single-batch and cross-batch analysis and reporting.
Dive deeper into the platform.
L7|SYNAPSE™ Datasheet
L7|SYNAPSE™ is the agentic AI layer of L7|ESP®, connecting natural-language interaction with governed scientific data, approved documentation, user permissions, and workflow execution. Designed for regulated life sciences environments, it grounds responses in an organization’s own knowledge and operational context. This datasheet provides an introduction to L7|SYNAPSE and its capabilities for retrieving information across L7|ESP, generating…
DownloadL7|ESP® Platform Brochure
L7|ESP® is the Agentic Operating System for Precision Science, bringing workflow orchestration, data contextualization, scientific applications, and system connectivity into one operating environment. It supports research, development, manufacturing, quality, and diagnostics while preserving the relationships among processes, materials, instruments, people, and results as work is executed. This brochure provides an overview of the L7|ESP architecture,…
DownloadL7 MES Datasheet
L7 MES is the manufacturing execution system application within L7|ESP® for regulated pharmaceutical and advanced therapeutics production. It manages master batch records, electronic batch records, recipes, materials, samples, specifications, signatures, deviations, and quality review within connected manufacturing workflows. The datasheet introduces capabilities for dynamic process execution, conditional routing, review by exception, batch reporting, sample coordination…
DownloadL7 at CGMOM 2025 – Building the Digital Backbone for the Future of Scalable Cell Therapies
This recorded panel discussion from Cell and Gene Meeting on the Mesa 2025 brings together leaders from L7 Informatics, Dana-Farber, CTMC, and Cellipont to discuss how digital infrastructure supports scalable cell therapy manufacturing. The session explores system integration, real-time operations, and the path toward more reliable and accessible patient care.
WatchTestimonial of Mike O’Mara, COO of Cellipont Bioservices
Cellipont implemented L7|ESP™ and its integrated MES application to digitize cell therapy manufacturing recipes, streamline tech transfers, and enhance digital capabilities.
WatchSupporting Cellipont Bioservices in Their Mission to Advance Cell Therapy Development and Manufacturing
L7|ESP, with L7 MES, brings organizational excellence and efficiency to Cellipont’s cell and gene therapy processes by digitalizing and centralizing manufacturing processes and data, facilitating project, sample, and data tracking, optimizing quality review and inventory management, and increasing processing throughput and end-user quality of life.
ReadContract Pharma – Cell Therapy at Scale: Digitalizing Manufacturing for Compliance and Efficiency
In this Contract Pharma webinar, Cellipont and L7 Informatics explore how CDMOs can transform cell and gene therapy manufacturing with unified data and orchestrated workflows. Learn how to streamline tech transfers, enhance compliance, and lay the foundation for AI-ready operations that accelerate innovation and improve scalability in advanced therapies.
WatchWhy Life Sciences Manufacturing AI Keeps Failing at the Finish Line
Between 70% and 90% of AI initiatives in manufacturing never reach production. The reasons are rarely about the AI itself. L7 Informatics' Kevin McMahon identifies the three failure modes consistently killing life sciences manufacturing AI pilots: broken data architecture, missing organizational alignment, and absent change management. Drawing on Gartner's March 2026 MES Market Guide, he…
ReadWhat customers are saying.
The decision to deploy L7|ESP reflects our commitment to staying at the forefront of innovation in this dynamic field.